Biochemical Filter Suitability Screening for Endotoxin Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Biologic drug manufacturing processes face challenges in controlling endotoxin levels introduced by naturally-sourced filters, leading to potential contamination and costly batch losses due to late-stage detection of endotoxins.
Innovation Solution
A method for evaluating filter suitability using buffer solutions to disrupt endotoxin interactions, involving pre-rinsing, passing buffer solution through filters, and assaying for endotoxin presence, with periodic screening and alert/action systems to ensure compliance with predetermined thresholds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If naturally-sourced filters are used in biologic drug manufacturing, then filtration effectiveness is improved, but endotoxin contamination risk increases
Solution Approach 1:
The patent implements preliminary endotoxin screening of filters before they are used in biologic drug manufacturing. By testing filters proactively and rejecting those exceeding endotoxin thresholds, the system prevents contaminated filters from entering the production process, thereby maintaining filtration effectiveness while eliminating endotoxin contamination risk.
2Reliability
If endotoxin testing is performed at late stage of manufacturing, then product safety is improved, but production efficiency deteriorates
Solution Approach 1:
The patent shifts endotoxin detection to an early stage by screening filters before they contact cell culture fluids. This preliminary screening prevents endotoxin contamination from occurring in the first place, eliminating the need for costly and time-consuming late-stage batch rejections while ensuring product safety.
Solution Approach 2:
The patent establishes a feedback mechanism where filter performance is continuously monitored through endotoxin testing. Results feed back into the selection process, allowing real-time adjustment of filter usage and ensuring that only compliant filters are deployed, thereby maintaining both safety and efficiency.
3Ease of manufacture
If filter endotoxin levels are not monitored, then manufacturing simplicity is maintained, but contamination risk increases
Solution Approach 1:
The patent introduces a monitoring system that provides feedback on filter endotoxin levels. By implementing regular testing and using the results to guide filter selection and usage, the system maintains manufacturing simplicity while significantly reducing contamination risk through data-driven decision making.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances the efficiency and productivity of biologic purification processes by reducing endotoxin contamination risks, minimizing waste, and ensuring compliance with regulatory standards through proactive endotoxin detection and removal.
Implementation Method 1
charge modification resins... removing endotoxin from aqueous solutions and buffers through charge interaction
Implementation Method 2
LPS are hydrophobic due to their lipid tails... The combination of the hydrophobic and negatively charged characteristics in LPS can cause LPS to bind to many different types of molecules
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Embodiments of the present disclosure include methods and systems for detecting the presence of endotoxins in filters. For example, embodiments of the present disclosure are directed to methods and systems for improving in-process controls by detecting undesirable quantities of endotoxins in filters containing naturally-sourced materials prior to using those filters in the production of formulated drug substances.